Riot Platforms, Inc. — Director's Dealing 2010

Jan 4, 2010

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: AspenBio Pharma, Inc. (APPY)
CIK: 0001167419
Period of Report: 2009-12-30

Reporting Person: HEPLER DOUGLAS I (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2009-12-30	Common Stock	S	5000	$1.76	Disposed	9000	Indirect

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	5000	Direct

Footnotes

F1: Dr. Hepler disclaims beneficial ownership of the shares held by his spouse.